We inherently appreciate that developing robust analytical methods is a fundamental element of bringing a new drug substance to market. This capability is driven by dedicated analytical chemists with real-world, actionable experience using state-of-the-art technology.

With over 30 years of experience in API development and an in-house comprehensive range of analytical capabilities, we can support our customers with their projects at any stage throughout all clinical phases and into commercial production.

• Characterization
• Absolute Configuration
• Polymorphism
• Particle Sizing
• Compatibility
• Impurity Profiling
• Solid-State Characterization – DS

• Product-specific analytical methods are established for process control, product release, and intermediate/raw material releases
• Impurity tracking
• Reference standard characterization
• Specification development,
• Method transfer and validation
• Stability studies performed according to ICH guidelines
• Force degradation studies